Flagship Harbor Advisors, LLC Vertex Pharmaceuticals Inc Transaction History

Flagship Harbor Advisors, LLC

$1.74 Billion
Q3 2024

A detailed history of Flagship Harbor Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Flagship Harbor Advisors, LLC holds 1,522 shares of VRTX stock, worth $707,060. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,522

Previous 1,908 20.23%

Holding current value

$707,060

Previous $797,000 11.29%

% of portfolio

0.04%

Previous 0.05%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$460.0 - $505.78 $177,560 - $195,231	-386 Reduced 20.23%	1,522 $707,000
Q1 2024 Apr 16, 2024	SELL	$407.69 - $446.08 $1,630 - $1,784	-4 Reduced 0.21%	1,908 $797,000
Q4 2023 Jan 10, 2024	BUY	$343.0 - $410.68 $116,963 - $140,041	341 Added 21.71%	1,912 $777,000
Q3 2023 Oct 17, 2023	BUY	$338.18 - $362.46 $23,672 - $25,372	70 Added 4.66%	1,571 $546,000
Q2 2023 Jul 11, 2023	BUY	$314.42 - $351.91 $31,442 - $35,191	100 Added 7.14%	1,501 $528,000
Q1 2023 Apr 12, 2023	SELL	$283.23 - $323.1 $73,923 - $84,329	-261 Reduced 15.7%	1,401 $441,000
Q4 2022 Jan 13, 2023	SELL	$285.76 - $321.48 $17,717 - $19,931	-62 Reduced 3.6%	1,662 $0
Q3 2022 Oct 13, 2022	BUY	$273.83 - $305.53 $111,174 - $124,045	406 Added 30.8%	1,724 $499,000
Q2 2022 Jul 13, 2022	BUY	$234.96 - $292.55 $3,289 - $4,095	14 Added 1.07%	1,318 $371,000
Q1 2022 Apr 13, 2022	SELL	$221.42 - $260.97 $2,657 - $3,131	-12 Reduced 0.91%	1,304 $340,000
Q4 2021 Feb 10, 2022	BUY	$177.01 - $223.45 $37,880 - $47,818	214 Added 19.42%	1,316 $289,000
Q2 2021 Jul 26, 2021	BUY	$187.49 - $221.1 $206,613 - $243,652	1,102 New	1,102 $222,000
Q4 2020 Feb 08, 2021	SELL	$207.01 - $276.09 $164,365 - $219,215	-794 Closed	0 $0
Q3 2020 Oct 13, 2020	BUY	$255.65 - $303.1 $18,918 - $22,429	74 Added 10.28%	794 $216,000
Q2 2020 Jul 31, 2020	BUY	$225.48 - $295.8 $33,371 - $43,778	148 Added 25.87%	720 $209,000
Q1 2020 May 12, 2020	BUY	$199.77 - $247.81 $11,586 - $14,372	58 Added 11.28%	572 $136,000
Q2 2019 Jul 22, 2019	BUY	$164.61 - $190.37 $2,633 - $3,045	16 Added 3.21%	514 $94,000
Q4 2018 Jan 28, 2019	SELL	$151.91 - $192.21 $34,635 - $43,823	-228 Reduced 31.4%	498 $82,000
Q3 2018 Nov 05, 2018	SELL	$167.73 - $192.74 $1,845 - $2,120	-11 Reduced 1.49%	726 $139,000
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $107,395 - $125,260	737 New	737 $125,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.

Account

Flagship Harbor Advisors, LLC Vertex Pharmaceuticals Inc Transaction History